Summary

The global iPSC Cell Therapies market size was US$ 10400 million in 2025 and is forecast to reach a readjusted size of US$ 21950 million by 2032 with a CAGR of 11.4% during the forecast period 2026-2032.
Induced pluripotent stem cell (iPSC) cell therapy is a cutting-edge regenerative medicine technology that uses somatic cells to be converted into pluripotent stem cells through genetic reprogramming technology, and then differentiate into specific types of cells for the treatment of various diseases. This technology allows scientists to generate corresponding cells from the patient's own cells, reducing the risk of immune rejection.
In 2025, the North America iPSC Cell Therapies market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of iPSC Cell Therapies include Bayer(BlueRock Therapeutics), Notch Therapeutics, Evotec Group, Pluristyx, Inc, Cellino, Fate Therapeutics, Allogene Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Century Therapeutics, Resolution Therapeutics, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global iPSC Cell Therapies market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Bayer(BlueRock Therapeutics)
Notch Therapeutics
Evotec Group
Pluristyx, Inc
Cellino
Fate Therapeutics
Allogene Therapeutics, Inc.
Takeda Pharmaceutical Company Limited
Century Therapeutics
Resolution Therapeutics
Kenai
Garuda Therapeutics
Hebecell
Allele Biotechnology and Pharmaceuticals
Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us
ElevateBio
iCamumo
BeiGene, Ltd
LumiSTAR Biotechnology
Neukio Biotherapeutics
Help Therapeutics
Hopstem Biotechnology Inc.
Nuwacell Biotechnologies Co., Ltd.
ihan Biotech
iRegene
Allife Medicine
CellOrigin
XellSmart bio
ThinkingBioMed
Cell Inspire Bio
Hema Cell
Yuesai BIO
Cytovia
Segment by Type
Preclinical/Research Stage
Clinical Stage
Commercial Stage
Segment by Application
Neurodegenerative Diseases
Cardiovascular Diseases
Diabetes
Other
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of iPSC Cell Therapies market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the iPSC Cell Therapies value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Preclinical/Research Stage
1.2.3 Clinical Stage
1.2.4 Commercial Stage
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Neurodegenerative Diseases
1.3.3 Cardiovascular Diseases
1.3.4 Diabetes
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global iPSC Cell Therapies Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global iPSC Cell Therapies Market Share by Revenue, by Region (2021-2026)
2.4 Global iPSC Cell Therapies Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America iPSC Cell Therapies Market Size and Prospective (2021-2032)
2.5.2 Europe iPSC Cell Therapies Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific iPSC Cell Therapies Market Size and Prospective (2021-2032)
2.5.4 Latin America iPSC Cell Therapies Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa iPSC Cell Therapies Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global iPSC Cell Therapies Historical Market Size by Type (2021-2026)
3.2 Global iPSC Cell Therapies Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of iPSC Cell Therapies
4 Breakdown Data by Application
4.1 Global iPSC Cell Therapies Historical Market Size by Application (2021-2026)
4.2 Global iPSC Cell Therapies Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in iPSC Cell Therapies Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top iPSC Cell Therapies Players by Revenue (2021-2026)
5.1.2 Global iPSC Cell Therapies Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by iPSC Cell Therapies Revenue
5.4 Global iPSC Cell Therapies Market Concentration Analysis
5.4.1 Global iPSC Cell Therapies Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by iPSC Cell Therapies Revenue in 2025
5.5 Global Key Players of iPSC Cell Therapies Head Offices and Areas Served
5.6 Global Key Players of iPSC Cell Therapies, Product and Application
5.7 Global Key Players of iPSC Cell Therapies, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America iPSC Cell Therapies Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America iPSC Cell Therapies Market Size by Type (2021-2026)
6.1.2.2 North America iPSC Cell Therapies Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America iPSC Cell Therapies Market Size by Application (2021-2026)
6.1.3.2 North America iPSC Cell Therapies Market Share by Application (2021-2026)
6.1.4 North America iPSC Cell Therapies Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe iPSC Cell Therapies Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe iPSC Cell Therapies Market Size by Type (2021-2026)
6.2.2.2 Europe iPSC Cell Therapies Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe iPSC Cell Therapies Market Size by Application (2021-2026)
6.2.3.2 Europe iPSC Cell Therapies Market Share by Application (2021-2026)
6.2.4 Europe iPSC Cell Therapies Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific iPSC Cell Therapies Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific iPSC Cell Therapies Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific iPSC Cell Therapies Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific iPSC Cell Therapies Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific iPSC Cell Therapies Market Share by Application (2021-2026)
6.3.4 Asia-Pacific iPSC Cell Therapies Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America iPSC Cell Therapies Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America iPSC Cell Therapies Market Size by Type (2021-2026)
6.4.2.2 Latin America iPSC Cell Therapies Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America iPSC Cell Therapies Market Size by Application (2021-2026)
6.4.3.2 Latin America iPSC Cell Therapies Market Share by Application (2021-2026)
6.4.4 Latin America iPSC Cell Therapies Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa iPSC Cell Therapies Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa iPSC Cell Therapies Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa iPSC Cell Therapies Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa iPSC Cell Therapies Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa iPSC Cell Therapies Market Share by Application (2021-2026)
6.5.4 Middle East & Africa iPSC Cell Therapies Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Bayer(BlueRock Therapeutics)
7.1.1 Bayer(BlueRock Therapeutics) Company Details
7.1.2 Bayer(BlueRock Therapeutics) Business Overview
7.1.3 Bayer(BlueRock Therapeutics) iPSC Cell Therapies Introduction
7.1.4 Bayer(BlueRock Therapeutics) Revenue in iPSC Cell Therapies Business (2021-2026)
7.1.5 Bayer(BlueRock Therapeutics) Recent Development
7.2 Notch Therapeutics
7.2.1 Notch Therapeutics Company Details
7.2.2 Notch Therapeutics Business Overview
7.2.3 Notch Therapeutics iPSC Cell Therapies Introduction
7.2.4 Notch Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026)
7.2.5 Notch Therapeutics Recent Development
7.3 Evotec Group
7.3.1 Evotec Group Company Details
7.3.2 Evotec Group Business Overview
7.3.3 Evotec Group iPSC Cell Therapies Introduction
7.3.4 Evotec Group Revenue in iPSC Cell Therapies Business (2021-2026)
7.3.5 Evotec Group Recent Development
7.4 Pluristyx, Inc
7.4.1 Pluristyx, Inc Company Details
7.4.2 Pluristyx, Inc Business Overview
7.4.3 Pluristyx, Inc iPSC Cell Therapies Introduction
7.4.4 Pluristyx, Inc Revenue in iPSC Cell Therapies Business (2021-2026)
7.4.5 Pluristyx, Inc Recent Development
7.5 Cellino
7.5.1 Cellino Company Details
7.5.2 Cellino Business Overview
7.5.3 Cellino iPSC Cell Therapies Introduction
7.5.4 Cellino Revenue in iPSC Cell Therapies Business (2021-2026)
7.5.5 Cellino Recent Development
7.6 Fate Therapeutics
7.6.1 Fate Therapeutics Company Details
7.6.2 Fate Therapeutics Business Overview
7.6.3 Fate Therapeutics iPSC Cell Therapies Introduction
7.6.4 Fate Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026)
7.6.5 Fate Therapeutics Recent Development
7.7 Allogene Therapeutics, Inc.
7.7.1 Allogene Therapeutics, Inc. Company Details
7.7.2 Allogene Therapeutics, Inc. Business Overview
7.7.3 Allogene Therapeutics, Inc. iPSC Cell Therapies Introduction
7.7.4 Allogene Therapeutics, Inc. Revenue in iPSC Cell Therapies Business (2021-2026)
7.7.5 Allogene Therapeutics, Inc. Recent Development
7.8 Takeda Pharmaceutical Company Limited
7.8.1 Takeda Pharmaceutical Company Limited Company Details
7.8.2 Takeda Pharmaceutical Company Limited Business Overview
7.8.3 Takeda Pharmaceutical Company Limited iPSC Cell Therapies Introduction
7.8.4 Takeda Pharmaceutical Company Limited Revenue in iPSC Cell Therapies Business (2021-2026)
7.8.5 Takeda Pharmaceutical Company Limited Recent Development
7.9 Century Therapeutics
7.9.1 Century Therapeutics Company Details
7.9.2 Century Therapeutics Business Overview
7.9.3 Century Therapeutics iPSC Cell Therapies Introduction
7.9.4 Century Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026)
7.9.5 Century Therapeutics Recent Development
7.10 Resolution Therapeutics
7.10.1 Resolution Therapeutics Company Details
7.10.2 Resolution Therapeutics Business Overview
7.10.3 Resolution Therapeutics iPSC Cell Therapies Introduction
7.10.4 Resolution Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026)
7.10.5 Resolution Therapeutics Recent Development
7.11 Kenai
7.11.1 Kenai Company Details
7.11.2 Kenai Business Overview
7.11.3 Kenai iPSC Cell Therapies Introduction
7.11.4 Kenai Revenue in iPSC Cell Therapies Business (2021-2026)
7.11.5 Kenai Recent Development
7.12 Garuda Therapeutics
7.12.1 Garuda Therapeutics Company Details
7.12.2 Garuda Therapeutics Business Overview
7.12.3 Garuda Therapeutics iPSC Cell Therapies Introduction
7.12.4 Garuda Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026)
7.12.5 Garuda Therapeutics Recent Development
7.13 Hebecell
7.13.1 Hebecell Company Details
7.13.2 Hebecell Business Overview
7.13.3 Hebecell iPSC Cell Therapies Introduction
7.13.4 Hebecell Revenue in iPSC Cell Therapies Business (2021-2026)
7.13.5 Hebecell Recent Development
7.14 Allele Biotechnology and Pharmaceuticals
7.14.1 Allele Biotechnology and Pharmaceuticals Company Details
7.14.2 Allele Biotechnology and Pharmaceuticals Business Overview
7.14.3 Allele Biotechnology and Pharmaceuticals iPSC Cell Therapies Introduction
7.14.4 Allele Biotechnology and Pharmaceuticals Revenue in iPSC Cell Therapies Business (2021-2026)
7.14.5 Allele Biotechnology and Pharmaceuticals Recent Development
7.15 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us
7.15.1 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Company Details
7.15.2 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Business Overview
7.15.3 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us iPSC Cell Therapies Introduction
7.15.4 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Revenue in iPSC Cell Therapies Business (2021-2026)
7.15.5 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Recent Development
7.16 ElevateBio
7.16.1 ElevateBio Company Details
7.16.2 ElevateBio Business Overview
7.16.3 ElevateBio iPSC Cell Therapies Introduction
7.16.4 ElevateBio Revenue in iPSC Cell Therapies Business (2021-2026)
7.16.5 ElevateBio Recent Development
7.17 iCamumo
7.17.1 iCamumo Company Details
7.17.2 iCamumo Business Overview
7.17.3 iCamumo iPSC Cell Therapies Introduction
7.17.4 iCamumo Revenue in iPSC Cell Therapies Business (2021-2026)
7.17.5 iCamumo Recent Development
7.18 BeiGene, Ltd
7.18.1 BeiGene, Ltd Company Details
7.18.2 BeiGene, Ltd Business Overview
7.18.3 BeiGene, Ltd iPSC Cell Therapies Introduction
7.18.4 BeiGene, Ltd Revenue in iPSC Cell Therapies Business (2021-2026)
7.18.5 BeiGene, Ltd Recent Development
7.19 LumiSTAR Biotechnology
7.19.1 LumiSTAR Biotechnology Company Details
7.19.2 LumiSTAR Biotechnology Business Overview
7.19.3 LumiSTAR Biotechnology iPSC Cell Therapies Introduction
7.19.4 LumiSTAR Biotechnology Revenue in iPSC Cell Therapies Business (2021-2026)
7.19.5 LumiSTAR Biotechnology Recent Development
7.20 Neukio Biotherapeutics
7.20.1 Neukio Biotherapeutics Company Details
7.20.2 Neukio Biotherapeutics Business Overview
7.20.3 Neukio Biotherapeutics iPSC Cell Therapies Introduction
7.20.4 Neukio Biotherapeutics Revenue in iPSC Cell Therapies Business (2021-2026)
7.20.5 Neukio Biotherapeutics Recent Development
7.21 Help Therapeutics
7.21.1 Help Therapeutics Company Details
7.21.2 Help Therapeutics Business Overview
7.21.3 Help Therapeutics iPSC Cell Therapies Introduction
7.21.4 Help Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026)
7.21.5 Help Therapeutics Recent Development
7.22 Hopstem Biotechnology Inc.
7.22.1 Hopstem Biotechnology Inc. Company Details
7.22.2 Hopstem Biotechnology Inc. Business Overview
7.22.3 Hopstem Biotechnology Inc. iPSC Cell Therapies Introduction
7.22.4 Hopstem Biotechnology Inc. Revenue in iPSC Cell Therapies Business (2021-2026)
7.22.5 Hopstem Biotechnology Inc. Recent Development
7.23 Nuwacell Biotechnologies Co., Ltd.
7.23.1 Nuwacell Biotechnologies Co., Ltd. Company Details
7.23.2 Nuwacell Biotechnologies Co., Ltd. Business Overview
7.23.3 Nuwacell Biotechnologies Co., Ltd. iPSC Cell Therapies Introduction
7.23.4 Nuwacell Biotechnologies Co., Ltd. Revenue in iPSC Cell Therapies Business (2021-2026)
7.23.5 Nuwacell Biotechnologies Co., Ltd. Recent Development
7.24 ihan Biotech
7.24.1 ihan Biotech Company Details
7.24.2 ihan Biotech Business Overview
7.24.3 ihan Biotech iPSC Cell Therapies Introduction
7.24.4 ihan Biotech Revenue in iPSC Cell Therapies Business (2021-2026)
7.24.5 ihan Biotech Recent Development
7.25 iRegene
7.25.1 iRegene Company Details
7.25.2 iRegene Business Overview
7.25.3 iRegene iPSC Cell Therapies Introduction
7.25.4 iRegene Revenue in iPSC Cell Therapies Business (2021-2026)
7.25.5 iRegene Recent Development
7.26 Allife Medicine
7.26.1 Allife Medicine Company Details
7.26.2 Allife Medicine Business Overview
7.26.3 Allife Medicine iPSC Cell Therapies Introduction
7.26.4 Allife Medicine Revenue in iPSC Cell Therapies Business (2021-2026)
7.26.5 Allife Medicine Recent Development
7.27 CellOrigin
7.27.1 CellOrigin Company Details
7.27.2 CellOrigin Business Overview
7.27.3 CellOrigin iPSC Cell Therapies Introduction
7.27.4 CellOrigin Revenue in iPSC Cell Therapies Business (2021-2026)
7.27.5 CellOrigin Recent Development
7.28 XellSmart bio
7.28.1 XellSmart bio Company Details
7.28.2 XellSmart bio Business Overview
7.28.3 XellSmart bio iPSC Cell Therapies Introduction
7.28.4 XellSmart bio Revenue in iPSC Cell Therapies Business (2021-2026)
7.28.5 XellSmart bio Recent Development
7.29 ThinkingBioMed
7.29.1 ThinkingBioMed Company Details
7.29.2 ThinkingBioMed Business Overview
7.29.3 ThinkingBioMed iPSC Cell Therapies Introduction
7.29.4 ThinkingBioMed Revenue in iPSC Cell Therapies Business (2021-2026)
7.29.5 ThinkingBioMed Recent Development
7.30 Cell Inspire Bio
7.30.1 Cell Inspire Bio Company Details
7.30.2 Cell Inspire Bio Business Overview
7.30.3 Cell Inspire Bio iPSC Cell Therapies Introduction
7.30.4 Cell Inspire Bio Revenue in iPSC Cell Therapies Business (2021-2026)
7.30.5 Cell Inspire Bio Recent Development
7.31 Hema Cell
7.31.1 Hema Cell Company Details
7.31.2 Hema Cell Business Overview
7.31.3 Hema Cell iPSC Cell Therapies Introduction
7.31.4 Hema Cell Revenue in iPSC Cell Therapies Business (2021-2026)
7.31.5 Hema Cell Recent Development
7.32 Yuesai BIO
7.32.1 Yuesai BIO Company Details
7.32.2 Yuesai BIO Business Overview
7.32.3 Yuesai BIO iPSC Cell Therapies Introduction
7.32.4 Yuesai BIO Revenue in iPSC Cell Therapies Business (2021-2026)
7.32.5 Yuesai BIO Recent Development
7.33 Cytovia
7.33.1 Cytovia Company Details
7.33.2 Cytovia Business Overview
7.33.3 Cytovia iPSC Cell Therapies Introduction
7.33.4 Cytovia Revenue in iPSC Cell Therapies Business (2021-2026)
7.33.5 Cytovia Recent Development
8 iPSC Cell Therapies Market Dynamics
8.1 iPSC Cell Therapies Industry Trends
8.2 iPSC Cell Therapies Market Drivers
8.3 iPSC Cell Therapies Market Challenges
8.4 iPSC Cell Therapies Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global iPSC Cell Therapies Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global iPSC Cell Therapies Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market iPSC Cell Therapies Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global iPSC Cell Therapies Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global iPSC Cell Therapies Revenue Share by Region (2021-2026)
Table 6. Global iPSC Cell Therapies Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global iPSC Cell Therapies Revenue Share Forecast by Region (2027-2032)
Table 8. Global iPSC Cell Therapies Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global iPSC Cell Therapies Market Share by Revenue, by Type (2021-2026)
Table 10. Global iPSC Cell Therapies Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global iPSC Cell Therapies Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global iPSC Cell Therapies Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global iPSC Cell Therapies Market Share by Revenue, by Application (2021-2026)
Table 15. Global iPSC Cell Therapies Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global iPSC Cell Therapies Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in iPSC Cell Therapies Applications
Table 18. Global iPSC Cell Therapies Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global iPSC Cell Therapies Market Share by Players (2021-2026)
Table 20. Global Top iPSC Cell Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in iPSC Cell Therapies as of 2025)
Table 21. Ranking of Global Top iPSC Cell Therapies Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by iPSC Cell Therapies Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of iPSC Cell Therapies, Headquarters and Area Served
Table 24. Global Key Players of iPSC Cell Therapies, Product and Application
Table 25. Global Key Players of iPSC Cell Therapies, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America iPSC Cell Therapies Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America iPSC Cell Therapies Market Share by Revenue, by Company (2021-2026)
Table 29. North America iPSC Cell Therapies Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America iPSC Cell Therapies Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe iPSC Cell Therapies Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe iPSC Cell Therapies Market Share by Revenue, by Company (2021-2026)
Table 33. Europe iPSC Cell Therapies Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe iPSC Cell Therapies Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific iPSC Cell Therapies Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific iPSC Cell Therapies Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific iPSC Cell Therapies Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific iPSC Cell Therapies Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America iPSC Cell Therapies Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America iPSC Cell Therapies Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America iPSC Cell Therapies Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America iPSC Cell Therapies Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa iPSC Cell Therapies Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa iPSC Cell Therapies Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa iPSC Cell Therapies Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa iPSC Cell Therapies Market Size by Application (2021-2026) & (US$ Million)
Table 47. Bayer(BlueRock Therapeutics) Company Details
Table 48. Bayer(BlueRock Therapeutics) Business Overview
Table 49. Bayer(BlueRock Therapeutics) iPSC Cell Therapies Product
Table 50. Bayer(BlueRock Therapeutics) Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 51. Bayer(BlueRock Therapeutics) Recent Development
Table 52. Notch Therapeutics Company Details
Table 53. Notch Therapeutics Business Overview
Table 54. Notch Therapeutics iPSC Cell Therapies Product
Table 55. Notch Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 56. Notch Therapeutics Recent Development
Table 57. Evotec Group Company Details
Table 58. Evotec Group Business Overview
Table 59. Evotec Group iPSC Cell Therapies Product
Table 60. Evotec Group Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 61. Evotec Group Recent Development
Table 62. Pluristyx, Inc Company Details
Table 63. Pluristyx, Inc Business Overview
Table 64. Pluristyx, Inc iPSC Cell Therapies Product
Table 65. Pluristyx, Inc Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 66. Pluristyx, Inc Recent Development
Table 67. Cellino Company Details
Table 68. Cellino Business Overview
Table 69. Cellino iPSC Cell Therapies Product
Table 70. Cellino Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 71. Cellino Recent Development
Table 72. Fate Therapeutics Company Details
Table 73. Fate Therapeutics Business Overview
Table 74. Fate Therapeutics iPSC Cell Therapies Product
Table 75. Fate Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 76. Fate Therapeutics Recent Development
Table 77. Allogene Therapeutics, Inc. Company Details
Table 78. Allogene Therapeutics, Inc. Business Overview
Table 79. Allogene Therapeutics, Inc. iPSC Cell Therapies Product
Table 80. Allogene Therapeutics, Inc. Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 81. Allogene Therapeutics, Inc. Recent Development
Table 82. Takeda Pharmaceutical Company Limited Company Details
Table 83. Takeda Pharmaceutical Company Limited Business Overview
Table 84. Takeda Pharmaceutical Company Limited iPSC Cell Therapies Product
Table 85. Takeda Pharmaceutical Company Limited Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 86. Takeda Pharmaceutical Company Limited Recent Development
Table 87. Century Therapeutics Company Details
Table 88. Century Therapeutics Business Overview
Table 89. Century Therapeutics iPSC Cell Therapies Product
Table 90. Century Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 91. Century Therapeutics Recent Development
Table 92. Resolution Therapeutics Company Details
Table 93. Resolution Therapeutics Business Overview
Table 94. Resolution Therapeutics iPSC Cell Therapies Product
Table 95. Resolution Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 96. Resolution Therapeutics Recent Development
Table 97. Kenai Company Details
Table 98. Kenai Business Overview
Table 99. Kenai iPSC Cell Therapies Product
Table 100. Kenai Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 101. Kenai Recent Development
Table 102. Garuda Therapeutics Company Details
Table 103. Garuda Therapeutics Business Overview
Table 104. Garuda Therapeutics iPSC Cell Therapies Product
Table 105. Garuda Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 106. Garuda Therapeutics Recent Development
Table 107. Hebecell Company Details
Table 108. Hebecell Business Overview
Table 109. Hebecell iPSC Cell Therapies Product
Table 110. Hebecell Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 111. Hebecell Recent Development
Table 112. Allele Biotechnology and Pharmaceuticals Company Details
Table 113. Allele Biotechnology and Pharmaceuticals Business Overview
Table 114. Allele Biotechnology and Pharmaceuticals iPSC Cell Therapies Product
Table 115. Allele Biotechnology and Pharmaceuticals Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 116. Allele Biotechnology and Pharmaceuticals Recent Development
Table 117. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Company Details
Table 118. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Business Overview
Table 119. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us iPSC Cell Therapies Product
Table 120. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 121. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Recent Development
Table 122. ElevateBio Company Details
Table 123. ElevateBio Business Overview
Table 124. ElevateBio iPSC Cell Therapies Product
Table 125. ElevateBio Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 126. ElevateBio Recent Development
Table 127. iCamumo Company Details
Table 128. iCamumo Business Overview
Table 129. iCamumo iPSC Cell Therapies Product
Table 130. iCamumo Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 131. iCamumo Recent Development
Table 132. BeiGene, Ltd Company Details
Table 133. BeiGene, Ltd Business Overview
Table 134. BeiGene, Ltd iPSC Cell Therapies Product
Table 135. BeiGene, Ltd Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 136. BeiGene, Ltd Recent Development
Table 137. LumiSTAR Biotechnology Company Details
Table 138. LumiSTAR Biotechnology Business Overview
Table 139. LumiSTAR Biotechnology iPSC Cell Therapies Product
Table 140. LumiSTAR Biotechnology Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 141. LumiSTAR Biotechnology Recent Development
Table 142. Neukio Biotherapeutics Company Details
Table 143. Neukio Biotherapeutics Business Overview
Table 144. Neukio Biotherapeutics iPSC Cell Therapies Product
Table 145. Neukio Biotherapeutics Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 146. Neukio Biotherapeutics Recent Development
Table 147. Help Therapeutics Company Details
Table 148. Help Therapeutics Business Overview
Table 149. Help Therapeutics iPSC Cell Therapies Product
Table 150. Help Therapeutics Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 151. Help Therapeutics Recent Development
Table 152. Hopstem Biotechnology Inc. Company Details
Table 153. Hopstem Biotechnology Inc. Business Overview
Table 154. Hopstem Biotechnology Inc. iPSC Cell Therapies Product
Table 155. Hopstem Biotechnology Inc. Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 156. Hopstem Biotechnology Inc. Recent Development
Table 157. Nuwacell Biotechnologies Co., Ltd. Company Details
Table 158. Nuwacell Biotechnologies Co., Ltd. Business Overview
Table 159. Nuwacell Biotechnologies Co., Ltd. iPSC Cell Therapies Product
Table 160. Nuwacell Biotechnologies Co., Ltd. Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 161. Nuwacell Biotechnologies Co., Ltd. Recent Development
Table 162. ihan Biotech Company Details
Table 163. ihan Biotech Business Overview
Table 164. ihan Biotech iPSC Cell Therapies Product
Table 165. ihan Biotech Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 166. ihan Biotech Recent Development
Table 167. iRegene Company Details
Table 168. iRegene Business Overview
Table 169. iRegene iPSC Cell Therapies Product
Table 170. iRegene Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 171. iRegene Recent Development
Table 172. Allife Medicine Company Details
Table 173. Allife Medicine Business Overview
Table 174. Allife Medicine iPSC Cell Therapies Product
Table 175. Allife Medicine Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 176. Allife Medicine Recent Development
Table 177. CellOrigin Company Details
Table 178. CellOrigin Business Overview
Table 179. CellOrigin iPSC Cell Therapies Product
Table 180. CellOrigin Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 181. CellOrigin Recent Development
Table 182. XellSmart bio Company Details
Table 183. XellSmart bio Business Overview
Table 184. XellSmart bio iPSC Cell Therapies Product
Table 185. XellSmart bio Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 186. XellSmart bio Recent Development
Table 187. ThinkingBioMed Company Details
Table 188. ThinkingBioMed Business Overview
Table 189. ThinkingBioMed iPSC Cell Therapies Product
Table 190. ThinkingBioMed Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 191. ThinkingBioMed Recent Development
Table 192. Cell Inspire Bio Company Details
Table 193. Cell Inspire Bio Business Overview
Table 194. Cell Inspire Bio iPSC Cell Therapies Product
Table 195. Cell Inspire Bio Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 196. Cell Inspire Bio Recent Development
Table 197. Hema Cell Company Details
Table 198. Hema Cell Business Overview
Table 199. Hema Cell iPSC Cell Therapies Product
Table 200. Hema Cell Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 201. Hema Cell Recent Development
Table 202. Yuesai BIO Company Details
Table 203. Yuesai BIO Business Overview
Table 204. Yuesai BIO iPSC Cell Therapies Product
Table 205. Yuesai BIO Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 206. Yuesai BIO Recent Development
Table 207. Cytovia Company Details
Table 208. Cytovia Business Overview
Table 209. Cytovia iPSC Cell Therapies Product
Table 210. Cytovia Revenue in iPSC Cell Therapies Business (2021-2026) & (US$ Million)
Table 211. Cytovia Recent Development
Table 212. iPSC Cell Therapies Market Trends
Table 213. iPSC Cell Therapies Market Drivers
Table 214. iPSC Cell Therapies Market Challenges
Table 215. iPSC Cell Therapies Market Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources


List of Figures
Figure 1. iPSC Cell Therapies Product Picture
Figure 2. Global iPSC Cell Therapies Market Share by Type: 2025 vs 2032
Figure 3. Preclinical/Research Stage Features
Figure 4. Clinical Stage Features
Figure 5. Commercial Stage Features
Figure 6. Global iPSC Cell Therapies Market Share by Application: 2025 vs 2032
Figure 7. Neurodegenerative Diseases
Figure 8. Cardiovascular Diseases
Figure 9. Diabetes
Figure 10. Other
Figure 11. iPSC Cell Therapies Report Years Considered
Figure 12. Global iPSC Cell Therapies Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 13. Global iPSC Cell Therapies Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global iPSC Cell Therapies Market Share by Revenue, by Region: 2021 vs 2025
Figure 15. North America iPSC Cell Therapies Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Europe iPSC Cell Therapies Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Asia-Pacific iPSC Cell Therapies Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Latin America iPSC Cell Therapies Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Middle East & Africa iPSC Cell Therapies Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Global iPSC Cell Therapies Market Share by Players in 2025
Figure 21. Global Top iPSC Cell Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in iPSC Cell Therapies as of 2025)
Figure 22. The Top 10 and 5 Players Market Share by iPSC Cell Therapies Revenue in 2025
Figure 23. North America iPSC Cell Therapies Market Share by Type (2021-2026)
Figure 24. North America iPSC Cell Therapies Market Share by Application (2021-2026)
Figure 25. Europe iPSC Cell Therapies Market Share by Type (2021-2026)
Figure 26. Europe iPSC Cell Therapies Market Share by Application (2021-2026)
Figure 27. Asia-Pacific iPSC Cell Therapies Market Share by Type (2021-2026)
Figure 28. Asia-Pacific iPSC Cell Therapies Market Share by Application (2021-2026)
Figure 29. Latin America iPSC Cell Therapies Market Share by Type (2021-2026)
Figure 30. Latin America iPSC Cell Therapies Market Share by Application (2021-2026)
Figure 31. Middle East & Africa iPSC Cell Therapies Market Share by Type (2021-2026)
Figure 32. Middle East & Africa iPSC Cell Therapies Market Share by Application (2021-2026)
Figure 33. Bayer(BlueRock Therapeutics) Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 34. Notch Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 35. Evotec Group Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 36. Pluristyx, Inc Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 37. Cellino Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 38. Fate Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 39. Allogene Therapeutics, Inc. Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 40. Takeda Pharmaceutical Company Limited Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 41. Century Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 42. Resolution Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 43. Kenai Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 44. Garuda Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 45. Hebecell Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 46. Allele Biotechnology and Pharmaceuticals Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 47. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 48. ElevateBio Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 49. iCamumo Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 50. BeiGene, Ltd Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 51. LumiSTAR Biotechnology Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 52. Neukio Biotherapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 53. Help Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 54. Hopstem Biotechnology Inc. Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 55. Nuwacell Biotechnologies Co., Ltd. Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 56. ihan Biotech Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 57. iRegene Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 58. Allife Medicine Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 59. CellOrigin Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 60. XellSmart bio Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 61. ThinkingBioMed Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 62. Cell Inspire Bio Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 63. Hema Cell Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 64. Yuesai BIO Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 65. Cytovia Revenue Growth Rate in iPSC Cell Therapies Business (2021-2026)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed